-
公开(公告)号：US20240350477A1
公开(公告)日：2024-10-24
申请号：US18359214
申请日：2023-07-26
申请人： Exelixis, Inc.
发明人： Dana T. Aftab , Gisela Schwab , Colin Hessel , Christian Scheffold , Steven Lacy , Dale Miles , Alan Arroyo , Mark Dean
CPC分类号： A61K31/47 , A61K9/2009 , A61K9/2018 , A61K9/2054 , A61K9/2866 , A61K31/16 , A61P35/00
摘要： The present disclosure relates to a method of treating advanced renal cell carcinoma (RCC) in human patients who have received prior anti-angiogenic therapy using CABOMETYX, a kinase inhibitor.
-
公开(公告)号：US20230045783A9
公开(公告)日：2023-02-09
申请号：US17468103
申请日：2021-09-07
申请人： Exelixis, Inc.
发明人： Dana T. Aftab , Gisela Schwab , Colin Hessel , Christian Scheffold , Steven Lacy , Dale Miles , Alan Arroyo , Mark Dean
摘要： The present disclosure relates to a method of treating advanced renal cell carcinoma (RCC) in human patients who have received prior anti-angiogenic therapy using CABOMETYX, a kinase inhibitor.
-
公开(公告)号：US20220401433A1
公开(公告)日：2022-12-22
申请号：US17888356
申请日：2022-08-15
申请人： Exelixis, Inc.
发明人： Dana T. Aftab , Gisela Schwab , Colin Hessel , Christian Scheffold , Steven Lacy , Dale Miles , Alan Arroyo , Mark Dean
摘要： The present disclosure relates to a method of treating advanced renal cell carcinoma (RCC) in human patients who have received prior anti-angiogenic therapy using CABOMETYX, a kinase inhibitor.
-
公开(公告)号：US20190209547A1
公开(公告)日：2019-07-11
申请号：US16093426
申请日：2017-04-17
申请人： Exelixis, Inc.
发明人： Dana T. Aftab , Gisela Schwab , Colin Hessel , Christian Scheffold , Steven Lacy , Dale Miles , Alan Arroyo , Mark Dean
CPC分类号： A61K31/47 , A61K9/2009 , A61K9/2018 , A61K9/2054 , A61K9/2866 , A61K31/16 , A61P35/00
摘要： The present disclosure relates to a method of treating advanced renal cell carcinoma (RCC) in human patients who have received prior anti-angiogenic therapy using CABOMETYX, a kinase inhibitor.
-
公开(公告)号：US20220000857A1
公开(公告)日：2022-01-06
申请号：US17468103
申请日：2021-09-07
申请人： Exelixis, Inc.
发明人： Dana T. Aftab , Gisela Schwab , Colin Hessel , Christian Scheffold , Steven Lacy , Dale Miles , Alan Arroyo , Mark Dean
摘要： The present disclosure relates to a method of treating advanced renal cell carcinoma (RCC) in human patients who have received prior anti-angiogenic therapy using CABOMETYX, a kinase inhibitor.
-
公开(公告)号：US11141413B2
公开(公告)日：2021-10-12
申请号：US16093426
申请日：2017-04-17
申请人： Exelixis, Inc.
发明人： Dana T. Aftab , Gisela Schwab , Colin Hessel , Christian Scheffold , Steven Lacy , Dale Miles , Alan Arroyo , Mark Dean
摘要： The present disclosure relates to a method of treating advanced renal cell carcinoma (RCC) in human patients who have received prior anti-angiogenic therapy using CABOMETYX, a kinase inhibitor.
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.015 秒)
